The aim of this study is to determine whether there is a role of podoplanin and glutathione S-transferases T1 (GST-T1) expression in laryngeal squamous cell carcinoma.
some tumors of the central nervous system (CNS) (8) (9) (10) (11) (12) (13) (14) (15) (16) . Increased expression of podoplanin may cause a higher rate of lymph node metastasis (17) .
In addition, patients with lymph node metastasis and upregulated podoplanin expression had shorter disease-specific survival rate than other patients.
According to the diagnosis, 25 % of cases have regional and 8-10% have distant metastasis (17, 18) . Podoplanin is frequently expressed in cutaneous head and neck squamous cell carcinoma (HNSCC) and may serve as predictor for regional lymph node metastasis, locoregional recurrence, and clinical outcome (19) . It has been shown that individuals carrying the null genotype of GST have significantly reduced activity of this antioxidant enzyme (27, 28) and so have higher levels of intermediates of oxidative metabolism. This genotype is related with many diseases (29, 30) . The revealed alterations in expression of GST-T1 enzyme can cause activation of carcinogenic particles or extinction of toxic effects. Therefore, it is thought that GST-T1 enzyme may be an important biomarker for diagnosis of laryngeal cancer. The aim of the study is to determine whether there is a role of podoplanin and GST-T1 in laryngeal SCC. 
Materials and Methods

Patients
Statistical analysis
All statistical analyses were performed using the SPSS version 13.0. The relationship between the podoplanin expression statuses and clinicopathologic parameters was analyzed using the Pearson's chi-square test or Fisher's exact test.
All tests were two-sided, and the P values less than 0.05 were considered statistically significant.
Results
Tissue samples were obtained from 42 patients with laryngeal carcinoma, but the tissues of 9 patients were excluded from the study because of technical reasons. Therefore, the study was completed in 33 patients whose mean age±SD was 58.03±11.10 years. All patients were male. Thirtyone patients were smokers, whereas tree patients used alcohol regularly (Table 1) . Of all, 20 patients had supraglottic, and the remaining 13 had glottic laryngeal SCC. Podoplanin overexpression was found in 14 patients and on the other hand decreased podoplanin expression was found in 19 patients (Fig.1) . The association between the patient characteristics and their podoplanin expressions was shown in (Table 2) . GST-T1 expression was not detected. 
